Innovative Reforms Could Reduce Time And Cost Of Drug Approvals

Henry I. Miller, a fellow at the Hoover Institution and the Competitive Enterprise Institute, a former official at the FDA, and the author of “To America’s Health: A Proposal to Reform the FDA.”